Clinical Trial Update: A Study to Evaluate the Safety of Escalating Doses of Ocrelizumab in Subjects With Rheumatoid Arthritis [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial evaluated the safety of escalating doses of ocrelizumab in adults with rheumatoid arthritis in Phase 1 and Phase 2. The study status is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Ocrevus (ocrelizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Rheumatoid Arthritis | Phase 1, Phase 2 | Status: COMPLETED